There are new treatments that can significantly slow down the progression of kidney disease, giving hope to the hundreds of thousands of people in Singapore suffering from early-stage kidney disease.
This is especially since the class of drugs called sodium glucose cotransporter-2 (SGLT2) inhibitors was placed on the standard drug list in November 2023, meaning it has become subsidised. It had been on the Medication Assistance Fund for the past two years, but that provides subsidies only for patients who have been means-tested.
SGLT2 inhibitors can slow down the progression of kidney failure by 37 per cent, said Dr Chua Horng Ruey, an expert in kidney disease at the National University Hospital (NUH).
While such drugs had originally been marketed as medication for diabetes, they have since been proven effective in slowing down the deterioration of kidney function in both people with and without diabetes.
Dr Chua, who heads the division of nephrology, or kidney disease, at NUH, said there is now "a wealth of more advanced therapeutics to treat chronic kidney disease, and especially diabetic kidney disease".
He said that if SGLT2 treatment is started in the early stage of kidney disease, when kidney function is still good, it might add 20 more years of kidney function versus without medication. If treatment is started later, when the disease is more advanced, it could still delay the need for dialysis by a couple more years.
How long it takes for someone to progress from stage 1 to 5 can vary significantly, from a few years to two decades or more.
This story is from the March 16, 2024 edition of The Straits Times.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the March 16, 2024 edition of The Straits Times.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
DEFENCE BEHIND BOSTON'S SUCCESS
Celtics on track for record 18th title; youthful Thunder continue to rumble to take lead in semis
A BETTER TOMORROW LOOMING
Stablemates Fast And Fearless and Fountain Of Fame also well
UOB QI profit down 2% amid drop in net interest margin
UOB had a muted start to 2024 as its margins from interest rates dropped, even as loans picked up pace and fee income rose.
US said to have revoked Qualcomm, Intel licences for exports to Huawei
The United States has revoked licences that allowed companies including Intel and Qualcomm to ship chips used for laptops and handsets to sanctioned Chinese telecoms equipment maker Huawei Technologies, three people familiar with the matter said.
Mexico City wins Lee Kuan Yew World City Prize
Mexico City has been named the winner of the Lee Kuan Yew World City Prize 2024.
MOH limited in what it can do on Cordlife customer refunds: Janil
He says Govt is not party to contracts for a private service and cannot overstep law
Bill to extend regulatory control over key transport firms passed
It will not create major compliance costs or interfere in commercial decisions: Minister
ERP 2.0 early adopters can reposition unit to driver's side for free: Chee Hong Tat
Motorists who have had the nextgeneration Electronic Road Pricing system (ERP 2.0) on-board units (OBU) installed in their vehicles as at May 2 can reposition the processing units from the passenger's footwell to the driver's footwell for free if they wish, said Transport Minister Chee Hong Tat.
Baltimore bridge collapse: Body of final victim found
The body of the sixth and final victim who died in the collapse of the Francis Scott Key Bridge in Baltimore was found on May 7, officials said, bringing to a close a difficult salvage mission after the United States' deadliest bridge collapse in more than a decade.
Porn star testifies about sex with Trump, hush money payout
His lawyers attack her credibility but their request to seek a mistrial gets denied